These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1902336)

  • 41. [Elements in the detection of allo-immunization. For whom? When? How?].
    Cabaud JJ
    Soins Gynecol Obstet Pueric Pediatr; 1983; (27-28):11-3. PubMed ID: 6419358
    [No Abstract]   [Full Text] [Related]  

  • 42. [Identification of alloantibodies and their associations: Balance sheet of 3 years at the Regional Center of Blood Transfusion in Rabat/Morocco and difficult in transfusion management].
    Achargui S; Zidouh A; Abirou S; Merhfour FZ; Monsif S; Amahrouch S; El Ghobre A; El Halhali M; Temmara H; El Hryfy A; Motqi M; Satty A; Kandili M; Aghri M; Hajjout K; Benajiba M
    Transfus Clin Biol; 2017 Nov; 24(4):422-430. PubMed ID: 28576386
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Identification strategy of RHCE gene variants at the National Blood Group Reference Laboratory: impact on transfusion safety].
    Ansart-Pirenne H
    Transfus Clin Biol; 2006; 13(1-2):13-8. PubMed ID: 16563835
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Blood groupings and antibody screening in Japanese Red Cross Blood Centers].
    Okubo Y
    Rinsho Byori; 1991 Mar; Suppl 88():50-9. PubMed ID: 1906950
    [No Abstract]   [Full Text] [Related]  

  • 45. Blood ordering in obstetrics and gynecology: recommendations for the type and screen.
    Hill ST; Lavin JP
    Obstet Gynecol; 1983 Aug; 62(2):236-40. PubMed ID: 6408546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Automated detection of red cell antibodies in donor sera using an automated technology.
    Theuriere M; Zelenski KR; Moore VK; Logulo AC
    Transfusion; 1985; 25(3):257-60. PubMed ID: 4002312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A possible case of a haemolytic transfusion reaction caused by anti-Le(a) antibody.
    Duncan V; Pham HP; Williams LA
    Blood Transfus; 2015 Jul; 13(3):535-6. PubMed ID: 26057494
    [No Abstract]   [Full Text] [Related]  

  • 48. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Cox JV; Steane E; Cunningham G; Frenkel EP
    Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Solid phase techniques in blood group serology].
    Uthemann H; Sturmfels L; Lenhard V
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():47-51. PubMed ID: 8374289
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Rh blood group system and Rh antibodies].
    Kato T; Ishimaru K; Ikeda H
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():670-4. PubMed ID: 16111364
    [No Abstract]   [Full Text] [Related]  

  • 51. Evaluation of antisera for bloodstain grouping. I. ABH, MN, and Rh.
    Gaensslen RE; Lee HC; Pagliaro EM; Bremser JK
    J Forensic Sci; 1985 Jul; 30(3):632-54. PubMed ID: 3928805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Terminology for red cell surface antigens. ISBT Working Party Oslo Report. International Society of Blood Transfusion.
    Daniels GL; Anstee DJ; Cartron JP; Dahr W; Garratty G; Henry S; Jørgensen J; Judd WJ; Kornstad L; Levene C; Lomas-Francis C; Lubenko A; Moulds JJ; Moulds JM; Moulds M; Overbeeke M; Reid ME; Rouger P; Scott M; Seidl S; Sistonen P; Tani Y; Wendel S; Zelinski T
    Vox Sang; 1999; 77(1):52-7. PubMed ID: 10474091
    [No Abstract]   [Full Text] [Related]  

  • 53. [Analysis of irregular antibodies at the department of transfusion medicine of the Hamburg-Eppendorf University Hospital 1984-1988].
    Wittkopf D; Grundmann A; Sibrowski W; von Eisenhart-Rothe B; Kühnl P
    Infusionstherapie; 1990 Oct; 17(5):280-2. PubMed ID: 2127047
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of blood group antigen discrepancies on today's blood banks.
    Denomme GA
    MLO Med Lab Obs; 2014 Oct; 46(10):8-9. PubMed ID: 25665238
    [No Abstract]   [Full Text] [Related]  

  • 55. The antigens of Ii blood group system in a further case of i 2 (Bi 2 ) adult person.
    Dzierzkowa-Borodej W; Kaźmierczak Z; Ziemniak J
    Arch Immunol Ther Exp (Warsz); 1972; 20(6):851-9. PubMed ID: 4123758
    [No Abstract]   [Full Text] [Related]  

  • 56. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
    Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
    Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Strategy of pretransfusion diagnosis in planned operations--experiences with the BAB (blood group determination, antibody determination test, blood availability) system].
    Boden B; Matthes G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):570-6. PubMed ID: 2446999
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-Dob implicated as the cause of a delayed hemolytic transfusion reaction.
    Moheng MC; McCarthy P; Pierce SR
    Transfusion; 1985; 25(1):44-6. PubMed ID: 3969700
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blood-group antibodies and antigens in human brain tumor cysts.
    Murray KJ; Kay NE; Chou SN; Douglas SD
    Surg Forum; 1977; 28():456-8. PubMed ID: 569368
    [No Abstract]   [Full Text] [Related]  

  • 60. Interpretation of Rh antibodies.
    DAVIDSOHN I; STERN K
    Am J Clin Pathol; 1948 Sep; 18(9):690-9. PubMed ID: 18885490
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.